(Q42446031)

31 October 2017

title

Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue (English)

1 reference

31 October 2017

1 reference

Taborsky GJ Jr

1

1 reference

31 October 2017

Porte D Jr

series ordinal

2

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 April 1981

1 reference

American Journal of Physiology

31 October 2017

published in

1 reference

31 October 2017

volume

240

1 reference

31 October 2017

issue

4

1 reference

31 October 2017

page(s)

E407-13

1 reference

Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Mechanisms of Impaired Acute Insulin Release in Adult Onset Diabetes: Studies with Isoproterenol and Secretin*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Studies of secretin-stimulated insulin responses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Insulin responses to glucose: evidence for a two pool system in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

The Controversy Concerning Counterregulatory Hormone Secretion: A Hypothesis for the Prevention of Diabetic Ketoacidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

Physiology and pathophysiology of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1981.240.4.E407

10.1152/AJPENDO.1981.240.4.E407

21 January 2018

Identifiers

DOI

0 references

1 reference